Erythropoietin Terminated Phase 3 Trials for Anemia / Non-Small Cell Lung Carcinoma (NSCLC) / Lung Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00310232Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)